The clearance concept with special reference to determination of glomerular filtration rate in patients with fluid retention

Clin Physiol Funct Imaging. 2015 Jan;35(1):7-16. doi: 10.1111/cpf.12149. Epub 2014 Apr 20.

Abstract

In subjects without fluid retention, the total plasma clearance of a renal filtration indicator (inulin, (99m) Tc-DTPA, (51) Cr-EDTA) is close to the urinary plasma clearance. Conversely, in patients with fluid retention (oedema, pleural effusions, ascites), there is a substantial discrepancy between the total plasma clearance and the urinary plasma clearance. This is owing to delayed indicator distribution to smaller or larger parts of the interstitial space, which in patients with ascites may simulate a peritoneal dialysator. In patients with fluid retention, urinary plasma clearance should be assessed to obtain a correct measurement of the glomerular filtration rate (GFR). In theory, total plasma clearance with late samples (24-h, 48-h) may be applied in patients with fluid retention, but validation hereof has not been performed. Until such studies are completed, it is recommended that patients with fluid retention have their GFR measured by a urinary plasma clearance technique with controlled quantitative urinary sampling within a few hours after indicator injection.

Keywords: 51Cr-EDTA; ascites; capillary filtration; extraction; glomerular filtration rate; interstitial space; inulin; oedema; plasma clearance; volume of distribution.

Publication types

  • Review

MeSH terms

  • Computer Simulation
  • Diagnosis, Computer-Assisted / methods
  • Glomerular Filtration Rate*
  • Humans
  • Kidney Diseases / complications
  • Kidney Diseases / diagnosis*
  • Kidney Diseases / metabolism*
  • Metabolic Clearance Rate
  • Models, Biological
  • Radiopharmaceuticals / pharmacokinetics*
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Tomography, Emission-Computed, Single-Photon / methods
  • Water-Electrolyte Imbalance / diagnosis
  • Water-Electrolyte Imbalance / etiology
  • Water-Electrolyte Imbalance / metabolism*

Substances

  • Radiopharmaceuticals